List of Softbank's 11 biggest healthcare investments
What it does:10x Genomics makes software for researchers to perform single cell and whole genome sequencing. Its software can be used for immunotherapy and cell therapy research in cancer patients or patients with rare genetic disorders. The Silicon Valley-based company was founded by Serge Saxonov, formerly the founding director of research at consumer genetics company 23andMe. Deal details: SoftBank participated in the company's $125 million Series D funding round in 2018 that valued the company at $1.25 billion. It went public in September 2019 and was valued above $3.6 billion in its de...
Source: businessinsider.com